Showing results (1-10 of 294) with videos related to
Sort By:
Pageof 30
Clinical Therapeutics|March 10, 2015
Cytotoxic T-lymphocyte antigen-4 blockade in melanomaElizabeth I Buchbinder, David F McDermottHematology/Oncology Clinics of North America|June 2, 2014
Interferon, interleukin-2, and other cytokinesElizabeth I Buchbinder, David F McDermottHematology/Oncology Clinics of North America|March 24, 2021
Immune Checkpoint Therapies for MelanomaElizabeth I BuchbinderAmerican Journal of Clinical Oncology|November 13, 2015
CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their InhibitionElizabeth I Buchbinder, Anupam DesaiAmerican Journal of Clinical Dermatology|January 28, 2025
Individualized Neoantigen-Directed Melanoma TherapyKaram Khaddour, Elizabeth I BuchbinderCancer Journal (Sudbury, Mass.)|March 25, 2024
Is There a Current Role for Combination Chemotherapy or High-Dose Interleukin 2 in Melanoma?Julie Fishman, Elizabeth I BuchbinderTrends in Cancer|July 26, 2017
Biomarkers in Melanoma: Lessons from Translational MedicineElizabeth I Buchbinder, Keith T FlahertyCurrent Oncology Reports|November 27, 2019
The Evolution of Adjuvant Therapy for MelanomaJustine V Cohen, Elizabeth I BuchbinderHematology/Oncology Clinics of North America|March 6, 2019
Immunotherapy ToxicityCharlene M Mantia, Elizabeth I BuchbinderPageof 30